Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-23-252378
Filing Date
2023-10-06
Accepted
2023-10-06 16:08:57
Documents
1
Effectiveness Date
2023-10-06

Document Format Files

Seq Description Document Type Size
1 S-8 POS d508568ds8pos.htm S-8 POS 33578
  Complete submission text file 0001193125-23-252378.txt   34824
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-198865 | Film No.: 231314306
SIC: 2834 Pharmaceutical Preparations